Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 11—November 2005
Research

Cervical Human Papillomavirus Screening among Older Women

Matthew J. Grainge*, Rashmi Seth*, Li Guo*, Keith R. Neal*, Carol Coupland*, Paul Vryenhoef†, Jane Johnson†, and David Jenkins*
Author affiliations: *University of Nottingham Medical School, Nottingham, United Kingdom; †Nottingham City Hospital, Nottingham, United Kingdom

Main Article

Table 2

Numbers of women infected with human papillomavirus (HPV) at baseline and follow-up and HPV acquisition and clearance rates by age

Age (baseline) HPV status – (1988)
HPV status + (1988)
% HPV acquisition in 3 y (95% CI)* % HPV clearance in 3 y (95% CI)
– (1991) + (1991) – (1991) + (1991)
21 56 10 17 3 15.2† (8.4–25.7) 85.0‡ (64.0–94.8)
31 73 12 10 3 14.1† (8.3–23.1) 76.9‡ (49.7–91.8)
41 72 11 14 3 13.3† (7.6–22.0) 82.4‡ (59.0–85.4)
51 262 71 29 10 21.3 (17.3–26.0) 74.4 (58.9–85.4)
Total 463 104 70 19 18.3 (15.4–21.7) 78.7 (69.0–85.9)

*CI, confidence interval.
†Not significantly different from acquisition rate in women 51 years of age when using χ2test (p>0.05).
‡Not significantly different from clearance rate in women 51 years of age when using Fisher exact test (p>0.05).

Main Article

Page created: February 17, 2012
Page updated: February 17, 2012
Page reviewed: February 17, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external